THE MECHANISM OF PHOTOSENSITIZATION IN PHOTODYNAMIC THERAPY: PHOSPHORESCENCE BEHAVIOR OF PORPHYRIN DERIVATIVES IN SALINE SOLUTION CONTAINING HUMAN SERUM ALBUMIN

The phosphorescence properties, especially the dynamic behavior of metal free and metal complexed porphyrins, have been studied in phosphate buffered saline (PBS) containing0–3% human serum albumin (HSA). 6,7‐Bisaspartyl‐2,4‐bis (l‐hexyloxyethyl)‐deutero‐porphyrin (DP) and its gallium(III), zinc(II), and indium(III) complexes are used as photosensitizers. Upon irradiation, a solution of porphyrins containing more than 0.1% HSA shows phosphorescence with a lifetime longer than 1 ms. With an increase in irradiation time, phosphorescence intensities and lifetimes of porphyrins increase, depending upon their concentrations and triplet lifetimes, and approach saturated values close to those under deaerated conditions. The experimental results may be interpreted in terms of hypoxia induced by photosensitization in a local environment surrounding the sensitizer. The hypoxia is caused by the reaction between proteins and singlet molecular oxygen generated by photosensitization of porphyrins. Phosphorescence behavior of sensitizers in HSA PBS solution gives significant information for classifying photosensitizers as to their efficacy for photodynamic therapy.

[1]  E. Reddi,et al.  PHOTOKINETIC AND PHOTOPHYSICAL MEASUREMENTS OF THE SENSITIZED PHOTOOXIDATION OF THE TRYPTOPHYL RESIDUE IN N‐ACETYL TRYPTOPHANAMIDE AND IN HUMAN SERUM ALBUMIN , 1987, Photochemistry and photobiology.

[2]  J W Winkelman,et al.  PHOTOSENSITIZERS IN ORGANIZED MEDIA: SINGLET OXYGEN PRODUCTION AND SPECTRAL PROPERTIES , 1988, Photochemistry and photobiology.

[3]  B W Henderson,et al.  OXYGEN LIMITATION OF DIRECT TUMOR CELL KILL DURING PHOTODYNAMIC TREATMENT OF A MURINE TUMOR MODEL , 1989, Photochemistry and photobiology.

[4]  Takeshi Takemura,et al.  A Kinetic Study of Dual Phosphorescence of Halogenated Benzenes in Rigid Glass Solution. , 1986 .

[5]  T. Dougherty,et al.  Photoradiation therapy--clinical and drug advances. , 1983, Advances in experimental medicine and biology.

[6]  J. Moan.  PORPHYRIN PHOTOSENSITIZATION AND PHOTOTHERAPY , 1986, Photochemistry and photobiology.

[7]  N. Ohta,et al.  CRITICAL IMPORTANCE OF THE TRIPLET LIFETIME OF PHOTOSENSITIZER IN PHOTODYNAMIC THERAPY OF TUMOR , 1989, Photochemistry and photobiology.

[8]  Determination of rate constants of 1O2 consumption by 1O2 acceptors in weakly deactivating solvents , 1989 .

[9]  D. Kessel,et al.  HEMATOPORPHYRIN and HPD: PHOTOPHYSICS, PHOTOCHEMISTRY and PHOTOTHERAPY , 1984, Photochemistry and photobiology.

[10]  Takeshi Takemura,et al.  Dynamical study of triplet-triplet energy transfer in rigid solution , 1977 .

[11]  Takeshi Takemura,et al.  Kinetic study of triplet excimer formation in fluid solution by means of phosphorimetry , 1976 .

[12]  H. Kato,et al.  Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. , 1982, Chest.

[13]  T J Dougherty,et al.  Photodynamic therapy--new approaches. , 1989, Seminars in surgical oncology.

[14]  B W Henderson,et al.  Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. , 1987, Cancer research.

[15]  Y. Kubo,et al.  TUMOR IMAGING WITH [111niIn]MONO‐DTPA‐ETHYLENEGLYCOL‐Ga‐DEUTEROPORPHYRIN , 1987, Photochemistry and photobiology.